Nicorette Fruktmint (Nicotine Resinate)

Nicotine resinate, the active ingredient in Nicorette Fruktmint, is a nicotine replacement therapy presented as an oromucosal formulation for oral mucosal use. It helps adult smokers who wish to quit by reducing nicotine withdrawal symptoms and cravings, supporting a gradual reduction in tobacco dependence.

GNH USA supplies Nicorette Fruktmint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nicotine resinate is used in nicotine replacement therapy to aid smoking cessation.

Smoking cessation: assists adult smokers in quitting by alleviating withdrawal symptoms and cravings. Relapse prevention: helps maintain abstinence after quitting by providing controlled nicotine exposure. Tobacco use reduction: enables a step‑down approach for smokers who wish to gradually lower cigarette consumption.

Nicotine resinate may cause a range of adverse reactions.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Dizziness or light‑headedness - Headache - Hiccups or throat discomfort - Insomnia or sleep disturbances

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, difficulty breathing) - Chest pain or palpitations - Severe hypertension - Arrhythmias - Anaphylaxis (rare) - Persistent vomiting

Use of nicotine resinate requires careful consideration of certain safety aspects. - Cardiovascular assessment: patients with recent heart attack or uncontrolled hypertension should consult a physician before use. - Pregnancy and lactation: discuss potential risks with a healthcare provider; use only if clearly needed. - Concomitant nicotine products: avoid using other nicotine‑containing items to prevent overdose. - Duration of therapy: limit use to the recommended period and monitor for dependence. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine resinate can interact with other medicines, affecting safety and efficacy.

Major Interactions (Avoid): - Concurrent use of monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Use with other nicotine‑containing products (e.g., patches, e‑cigarettes): risk of nicotine toxicity.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., cimetidine): may raise nicotine plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked. - Alcohol: may enhance nicotine cravings and affect metabolism. - Certain antipsychotics (e.g., clozapine): nicotine may alter drug clearance.